Strategic Financial Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$623K Buy
519
+4
+0.8% +$4.09K 0.03% 94
2026
Q1
$474K Buy
515
+21
+4% +$21.3K 0.02% 106
2025
Q4
$523K Sell
494
-10
-2% -$9.56K 0.02% 95
2025
Q3
$385K Sell
504
-12
-2% -$8.93K 0.02% 104
2025
Q2
$402K Sell
516
-15
-3% -$11.7K 0.02% 100
2025
Q1
$439K Sell
531
-1
-0.2% -$832 0.03% 96
2024
Q4
$411K Sell
532
-43
-7% -$35.6K 0.02% 99
2024
Q3
$509K Hold
575
0.03% 92
2024
Q2
$521K Buy
+575
New +$460K 0.03% 84

Other funds holding LLY

Strategic Financial Services's LLY Position: Q2 2026 in Review

Strategic Financial Services increased its Eli Lilly (LLY) stake by 0.78% in Q2 2026, buying an estimated $4.09K and bringing the position to 519 shares worth $623K. The position accounts for 0.03% of the portfolio, ranked #94.

Strategic Financial Services first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Strategic Financial Services held 519 shares of Eli Lilly worth $623K as of Q2 2026.
  • Strategic Financial Services bought 4 Eli Lilly shares in Q2 2026, an estimated $4.09K.
  • Eli Lilly made up 0.03% of Strategic Financial Services's portfolio in Q2 2026, its #94 holding.
  • Strategic Financial Services first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Strategic Financial Services's 13F filing for Q2 2026, filed 24 Aug 2026.